Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons
- PMID: 17722006
- DOI: 10.1002/humu.20607
Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons
Abstract
Autosomal dominant optic atrophy (adOA) is most commonly caused by mutations in the OPA1 gene. There is a considerable allelic heterogeneity among adOA-associated OPA1 mutations, however these mutations have mostly been identified and studied only at the genomic DNA level. Here we report the identification of 22 novel OPA1 mutations and their analysis at the cDNA level along with 15 already known OPA1 mutations. We found that 18 of these mutations cause splice defects that involve either skipping of the adjacent exon or the activation of a cryptic splice site. We also observed a reduced level of the mutant transcript in several adOA subjects. Allele-specific quantification of the transcript steady-state level was performed for 13 different OPA1 mutations applying pyrosequencing to a RT-PCR amplified cSNP (c.2109C>T) in OPA1. Using this new assay we could demonstrate that the majority of OPA1 mutations that lead to a premature termination codon (PTC) undergo nonsense-mediated mRNA decay (NMD). Mutant transcript levels were reduced between 1.25- and 2.5-fold and varied between PTC containing mutations, and between subjects. Our results emphasize the value of cDNA analysis in the characterization of OPA1 mutations and further strengthen the model of haploinsufficiency as a major pathomechanism in OPA1-associated adOA.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1715-24. Invest Ophthalmol Vis Sci. 2002. PMID: 12036970
-
Dominant optic atrophy caused by a novel OPA1 splice site mutation (IVS20+1G-->A) associated with intron retention.Ophthalmic Res. 2005 Jul-Aug;37(4):214-24. doi: 10.1159/000086862. Epub 2005 Jul 5. Ophthalmic Res. 2005. PMID: 16006781
-
Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy.Hum Mutat. 2003 Jun;21(6):656. doi: 10.1002/humu.9152. Hum Mutat. 2003. PMID: 14961560
-
OPA1-associated disorders: phenotypes and pathophysiology.Int J Biochem Cell Biol. 2009 Oct;41(10):1855-65. doi: 10.1016/j.biocel.2009.04.012. Epub 2009 Apr 21. Int J Biochem Cell Biol. 2009. PMID: 19389487 Review.
-
OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.Mol Genet Metab. 2002 Feb;75(2):97-107. doi: 10.1006/mgme.2001.3278. Mol Genet Metab. 2002. PMID: 11855928 Review.
Cited by
-
Whole genome sequencing unveils genetic heterogeneity in optic nerve hypoplasia.PLoS One. 2020 Feb 10;15(2):e0228622. doi: 10.1371/journal.pone.0228622. eCollection 2020. PLoS One. 2020. PMID: 32040484 Free PMC article.
-
Reply: 'Behr syndrome' with OPA1 compound heterozygote mutations.Brain. 2015 Jan;138(Pt 1):e322. doi: 10.1093/brain/awu235. Epub 2014 Aug 21. Brain. 2015. PMID: 25146915 Free PMC article. No abstract available.
-
Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants.Ophthalmic Genet. 2018 Oct;39(5):569-576. doi: 10.1080/13816810.2018.1466337. Epub 2018 Jun 28. Ophthalmic Genet. 2018. PMID: 29952689 Free PMC article.
-
Inherited mitochondrial optic neuropathies.J Med Genet. 2009 Mar;46(3):145-58. doi: 10.1136/jmg.2007.054270. Epub 2008 Nov 10. J Med Genet. 2009. PMID: 19001017 Free PMC article. Review.
-
OPA1 Dominant Optic Atrophy: Diagnostic Approach in the Pediatric Population.Curr Issues Mol Biol. 2023 Jan 5;45(1):465-478. doi: 10.3390/cimb45010030. Curr Issues Mol Biol. 2023. PMID: 36661516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
